Anzeige
Mehr »
Login
Donnerstag, 19.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Revolutionäre Zukunftsaktie: Ihr Depot-Booster für bahnbrechende Renditen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DYN5 | ISIN: CA23809L1085 | Ticker-Symbol: D4G
Tradegate
18.12.24
20:02 Uhr
0,004 Euro
-0,002
-35,71 %
Branche
Hardware
Aktienmarkt
Sonstige
1-Jahres-Chart
DATAMETREX AI LIMITED Chart 1 Jahr
5-Tage-Chart
DATAMETREX AI LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
0,0030,00915:42
0,0040,00615:30
ACCESSWIRE
354 Leser
Artikel bewerten:
(2)

Datametrex AI Ltd.: Datametrex Implements AI Technology at Imagine Health Centres To Streamline Patient Care and Enhance Healthcare Accessibility

Finanznachrichten News

TORONTO, ON / ACCESSWIRE / September 10, 2024 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is excited to announce the implementation of advanced Artificial Intelligence (AI) technology at its Imagine Health Centres ("ImagineHealth") clinics in Calgary and Edmonton, Alberta. This initiative underscores the Company's commitment to harnessing AI to enhance healthcare services and accessibility across Canada.

As a technology leader, Datametrex is leveraging AI tools designed to streamline and automate the patient charting process. This innovative technology is able to dictate and automatically generate encounter notes based on conversations between physicians and patients, seamlessly integrating this information into the Electronic Medical Record ("EMR") system. The Company expects this new implementation to not only reduces the time spent on manual note-taking but also allows doctors to focus more on patient care.

Charles Park, CEO of Datametrex, commented, "We believe that the integration of AI into our clinics will significantly enhance the efficiency of our healthcare providers. This technology aims to improve patient experience by minimizing administrative burdens, allowing for a more streamlined and effective approach to care. Ultimately, we see this as a crucial step towards addressing some of the challenges surrounding healthcare accessibility in Canada."

The Company anticipates that this AI-powered tool will create a more efficient workflow for physicians, reduce wait times, and contribute to the ongoing efforts to provide more accessible and higher-quality healthcare solutions to Canadians. Furthermore, the Company is fully committed to maintaining the highest standards of privacy and security, ensuring that all patient information processed through the AI system is protected in accordance with applicable privacy regulations. Datametrex has implemented stringent security protocols to safeguard patient data.

About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

For more on Datametrex, please visit our YouTube channel and Company website.

For Additional Information
Charles Park, CFA
Chief Executive Officer & Director
cpark@datametrex.com
(416) 901-5611 x203

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to game development and other Company plans.

While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.

Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis for the year ended December 31, 2023, available on the Company's profile at www.sedarplus.ca.

This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.

SOURCE: Datametrex AI Ltd.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.